Flagship Pioneering, LLC - 10%+ Owner at Omega Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Flagship Pioneering, LLC since 28 Sep 2025

Reported holdings for Flagship Pioneering, LLC in Omega Therapeutics, Inc.

Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
8,617,413
Estimated value
$68,939,304
Report date
27 Feb 2023
Price
$8.00
Ownership
By Flagship Pioneering Fund VI, L.P.
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
7,508,693
Estimated value
$60,069,544
Report date
27 Feb 2023
Price
$8.00
Ownership
By Flagship Pioneering Special Opportunities Fund II, L.P.
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
5,896,386
Estimated value
$47,171,088
Report date
27 Feb 2023
Price
$8.00
Ownership
By Flagship Ventures Fund V, L.P.
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,197,059
Estimated value
$17,576,472
Report date
27 Feb 2023
Price
$8.00
Ownership
By Flagship VentureLabs V, LLC
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,617,646
Estimated value
$12,941,168
Report date
27 Feb 2023
Price
$8.00
Ownership
By FPN, L.P.
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,617,646
Estimated value
$12,941,168
Report date
03 Aug 2021
Price
$8.00
Ownership
Indirect
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,329,324
Estimated value
$10,634,592
Report date
27 Feb 2023
Price
$8.00
Ownership
By Flagship Pioneering Fund VII, L.P.
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
1,088,470
Estimated value
$8,707,760
Report date
27 Feb 2023
Price
$8.00
Ownership
By Flagship V VentureLabs Rx Fund, L.P.
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Common Stock
Shares / value
970,588
Estimated value
$7,764,704
Report date
27 Feb 2023
Price
$8.00
Ownership
By Nutritional Health LTP Fund, L.P.
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
03 Aug 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
03 Aug 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Omega Therapeutics, Inc.

Security class
Series C Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
03 Aug 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Transaction history for Flagship Pioneering, LLC in Omega Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .